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Background: Identification of patients with atrial fibrillation (AF) at low and intermediate risk for stroke remains imprecise. The objective was to 
validate and compare the predictive power of two widely-used risk scores, CHADS2 and CHA2DS2-VASc, in post-menopausal women with AF in the 
Women’s Health Initiative (WHI).
Methods: Participants were 5,981 women with AF not on warfarin at baseline (82.1% white, mean age 65.9±7.2 years) of the 161,809 enrolled 
in the WHI from 1993 to 1998 and followed for an average of 10.7 years. Univariate and multivariate proportional hazards analyses were used to 
examine each risk score. Outcome measures were event rate and hazard ratio (HR) of ischemic stroke or transient ischemic attack (TIA) stratified by 
risk score.
Results: Annualized stroke or TIA rates ranged from 0.36-2.43% with increasing CHADS2 score (0-4+) (HR 1.57, 95% confidence interval [CI] 1.45-
1.71 for each 1 point increase) and 0.20-2.02% with increasing CHA2DS2-VASc score (1-6+) (HR 1.50, 95% CI 1.41-1.60 for each 1 point increase). 
Both scores were predictive of stroke rates with c statistics 0.65 (95% CI, 0.62-0.67) and 0.67 (95% CI, 0.65-0.69) respectively. 41% of patients 
with CHADS2 < 2 were reclassified by CHA2DS2-VASc as having a stroke risk higher than even some patients with CHADS2 scores of 2 or 3 (Table 1).
Conclusions: Both CHADS2, and CHA2DS2-VASc are predictive of stroke risk in post-menopausal women with AF. CHA2DS2-VASc further risk-
stratifies patients with a CHADS2 score < 2. 
Table 1. Annualized Rates of Ischemic Stroke/TIA by CHADS21 and CHA2DS2-VASc2 Scores
CHA2DS2-VASc
Total Participants=5981 1 (n=951) 2 (n=1794) 3 (n=1799) 4 (n=911) 5 (n=343) 6+ (n=183)
CHADS2 0 (n=1760) 951 (0.201%) 755 (0.53%) 54 (0.91%)
1 (n=2879) 1039 (0.44%) 1601 (0.82%) 239 (1.43%)
2 (n=922) 144 (0.77%) 610 (1.29%) 168 (1.68%)
3 (n=299) 62 (0.98%) 169 (1.73%) 68 (1.19%)
4+ (n=121) 6 (1.61%) 115 (2.49%)
1 Congestive Heart Failure (C), Hypertension (H), Age ≥ 75 (A), Diabetes (D) = 1 point each; Stroke/TIA (S2) = 2 points
2 C, H, D, S2: Same as CHADS2; Age ≥ 75 (A2) = 2 points; Vascular Disease (V), Age 65-74 (A), Female Sex (S) = 1 point each
